BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 37581871)

  • 1. Metabolic phenotyping in people living with obesity: Implications for dietary prevention.
    Blaak EE; Goossens GH
    Rev Endocr Metab Disord; 2023 Oct; 24(5):825-838. PubMed ID: 37581871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural course of metabolically healthy phenotype and risk of developing Cardiometabolic diseases: a three years follow-up study.
    Elías-López D; Vargas-Vázquez A; Mehta R; Cruz Bautista I; Del Razo Olvera F; Gómez-Velasco D; Almeda Valdes P; Aguilar-Salinas CA;
    BMC Endocr Disord; 2021 Apr; 21(1):85. PubMed ID: 33910543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolically Healthy Obesity (MHO) vs. Metabolically Unhealthy Obesity (MUO) Phenotypes in PCOS: Association with Endocrine-Metabolic Profile, Adherence to the Mediterranean Diet, and Body Composition.
    Barrea L; Muscogiuri G; Pugliese G; de Alteriis G; Colao A; Savastano S
    Nutrients; 2021 Nov; 13(11):. PubMed ID: 34836180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolically healthy obesity: facts and fantasies.
    Smith GI; Mittendorfer B; Klein S
    J Clin Invest; 2019 Oct; 129(10):3978-3989. PubMed ID: 31524630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations of obesity phenotypes with weight change, cardiometabolic benefits, and type 2 diabetes incidence during a lifestyle intervention: results from the PREVIEW study.
    Zhu R; Huttunen-Lenz M; Stratton G; Handjieva-Darlenska T; Handjiev S; Sundvall J; Silvestre MP; Jalo E; Pietiläinen KH; Adam TC; Drummen M; Simpson EJ; Taylor MA; Poppitt SD; Navas-Carretero S; Martinez JA; Schlicht W; Fogelholm M; Brand-Miller J; Raben A
    Int J Obes (Lond); 2023 Sep; 47(9):833-840. PubMed ID: 37420008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolically unhealthy phenotype in adults with normal weight: Is cardiometabolic health worse off when compared to adults with obesity?
    Seo MW; Kim JY
    Obes Res Clin Pract; 2023; 17(2):116-121. PubMed ID: 36813589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association between transition from metabolically healthy obesity to metabolic syndrome, and incidence of cardiovascular disease: Tehran lipid and glucose study.
    Hosseinpanah F; Tasdighi E; Barzin M; Mahdavi M; Ghanbarian A; Valizadeh M; Azizi F
    PLoS One; 2020; 15(9):e0239164. PubMed ID: 32947607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mediterranean diet and mortality risk in metabolically healthy obese and metabolically unhealthy obese phenotypes.
    Park YM; Steck SE; Fung TT; Zhang J; Hazlett LJ; Han K; Merchant AT
    Int J Obes (Lond); 2016 Oct; 40(10):1541-1549. PubMed ID: 27339604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolically healthy obesity: definitions, determinants and clinical implications.
    Phillips CM
    Rev Endocr Metab Disord; 2013 Sep; 14(3):219-27. PubMed ID: 23928851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis, Murine Models, and Clinical Implications of Metabolically Healthy Obesity.
    Cho YK; Lee Y; Jung CH
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perspective: Metabotyping-A Potential Personalized Nutrition Strategy for Precision Prevention of Cardiometabolic Disease.
    Palmnäs M; Brunius C; Shi L; Rostgaard-Hansen A; Torres NE; González-Domínguez R; Zamora-Ros R; Ye YL; Halkjær J; Tjønneland A; Riccardi G; Giacco R; Costabile G; Vetrani C; Nielsen J; Andres-Lacueva C; Landberg R
    Adv Nutr; 2020 May; 11(3):524-532. PubMed ID: 31782487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolically Healthy Obesity, Transition to Metabolic Syndrome, and Cardiovascular Risk.
    Mongraw-Chaffin M; Foster MC; Anderson CAM; Burke GL; Haq N; Kalyani RR; Ouyang P; Sibley CT; Tracy R; Woodward M; Vaidya D
    J Am Coll Cardiol; 2018 May; 71(17):1857-1865. PubMed ID: 29699611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotyping obesity: A focus on metabolically healthy obesity and metabolically unhealthy normal weight.
    Agius R; Pace NP; Fava S
    Diabetes Metab Res Rev; 2024 Feb; 40(2):e3725. PubMed ID: 37792999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physical Activity and Risk of Metabolic Phenotypes of Obesity: A Prospective Taiwanese Cohort Study in More Than 200,000 Adults.
    Martinez-Gomez D; Ortega FB; Hamer M; Lopez-Garcia E; Struijk E; Sadarangani KP; Lavie CJ; Rodríguez-Artalejo F
    Mayo Clin Proc; 2019 Nov; 94(11):2209-2219. PubMed ID: 31619366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Which predictors differentiate between obese children and adolescents with cardiometabolic complications and those with metabolically healthy obesity?
    Margolis-Gil M; Yackobovitz-Gavan M; Phillip M; Shalitin S
    Pediatr Diabetes; 2018 Nov; 19(7):1147-1155. PubMed ID: 29802767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The presence of NAFLD influences the transition of metabolically healthy to metabolically unhealthy obesity and the ten-year cardiovascular disease risk: A population-based cohort study.
    Kouvari M; Chrysohoou C; Skoumas J; Pitsavos C; Panagiotakos DB; Mantzoros CS;
    Metabolism; 2022 Mar; 128():154893. PubMed ID: 34600906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lifestyle factors associated with the transition from healthy to unhealthy adiposity among black South African adults over 10 years.
    Kruger HS; Ricci C; Pieters M; Botha-le Roux S; Moss SJ; Kruger IM; van Zyl T; Schutte AE
    Nutr Metab Cardiovasc Dis; 2021 Jun; 31(7):2023-2032. PubMed ID: 33975737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolically Healthy Obesity: Criteria, Epidemiology, Controversies, and Consequences.
    Tsatsoulis A; Paschou SA
    Curr Obes Rep; 2020 Jun; 9(2):109-120. PubMed ID: 32301039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association Metabolic Obesity Phenotypes with Cardiometabolic Index, Atherogenic Index of Plasma and Novel Anthropometric Indices: A Link of FTO-rs9939609 Polymorphism.
    Abolnezhadian F; Hosseini SA; Alipour M; Zakerkish M; Cheraghian B; Ghandil P; Cheraghpour M
    Vasc Health Risk Manag; 2020; 16():249-256. PubMed ID: 32612360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transition from metabolically benign to metabolically unhealthy obesity and 10-year cardiovascular disease incidence: The ATTICA cohort study.
    Kouvari M; Panagiotakos DB; Yannakoulia M; Georgousopoulou E; Critselis E; Chrysohoou C; Tousoulis D; Pitsavos C;
    Metabolism; 2019 Apr; 93():18-24. PubMed ID: 30639450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.